NewsShowing 6 to 10 of 25 results
A new partnership between LLSC and BioCanRx will help Canadian scientists expand their ability to conduct clinical trials of CAR T therapy, an important new treatment for some blood cancers that have not responded to other treatments.
Like many people, the onset of COVID-19 in March 2020 was a catalyst for change in my life. Just into my fifties, I decided to quit my job, making a brief return to the classroom, and adding another feather to my professional cap.
If you have CLL, your immune system may be weakened by the disease and from the effects of treatments. This puts you at increased risk when it comes to COVID-19.
Going back to normal and yet staying safe is impossible, especially for those with CLL for whom getting infections is risky at best. So, the new “normal” is more of the same.